SCHEMBL5454953

SCHEMBL5454953

Cc1cc(C(=O)CN2CCC(O)(c3cccc(F)c3)CC2)ccc1OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
MRGPRX4 Q96LA9 2/20 0.48
GRIN2B Q13224 6/20 0.47
DRD2 P14416 3/20 0.43
ABCB1 P08183 2/20 0.43
MAPT P10636 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
OPRL1 P41146 1/20 0.42
FFAR4 Q5NUL3 1/20 0.41
ABCB11 O95342 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
THPO P40225 1/20 0.41
MTOR P42345 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5463013 0.87 NR4A2 (0.50) ALDH1A1GRIN2BDRD2ABCB1MAPT
SCHEMBL5463199 0.81 GRIN2B (0.52) GRIN2BABCB1FFAR4
SCHEMBL5455175 0.81 ABCB1 (0.42) ALDH1A1ABCB1MAPTFFAR4
SCHEMBL5457356 0.81 KCNH2 (0.54) ALDH1A1MRGPRX4GRIN2BABCB1OPRM1
SCHEMBL5702234 0.78 OPRM1 (0.49) ALDH1A1MRGPRX4ABCB1OPRM1OPRD1
SCHEMBL5457479 0.77 ALDH1A1 (0.49) ALDH1A1GRIN2BDRD2MAPTOPRM1
SCHEMBL5462690 0.77 GRIN2B (0.51) ALDH1A1GRIN2BDRD2ABCB1MAPT
SCHEMBL5470661 0.76 GRIN2B (0.52) ALDH1A1GRIN2BDRD2MAPTOPRM1
SCHEMBL5462772 0.76 CCR5 (0.45) MRGPRX4DRD2ABCB1SIGMAR1
SCHEMBL6816851 0.76 ABCB1 (0.45) MRGPRX4GRIN2BABCB1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070021414-A1 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists PFIZER, INC. 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021414-A1 1-'2-(4-Hydroxyphenyl)-2-hydroxyethyl!-piperidin-4-ol compounds as nmda receptor antagonists GRIN1, GRIN3A, GRIN2C ALDH1A1 893/4885MRGPRX4 441/4885GRIN2B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.